IL1B and neoplasm: aimed to assess the role of IL-1 as a driver of tumor angiogenesis and evaluate its potential as an anti-tumor agent, and by employing IL-1β knockout mice, the authors found that IL-1β is required for in vivo angiogenesis since IL-1β knockout mice failed to recruit blood vessel networks into Matrigel plugs with melanoma tumor cells.